Saeter G, Schwarze E, Seglen O
Department of Tissue Culture, Institute for Cancer Research, Norwegian Radium Hospital, Oslo.
J Natl Cancer Inst. 1988 Aug 17;80(12):950-8. doi: 10.1093/jnci/80.12.950.
Liver growth patterns in normal and carcinogen-treated young Wistar Kyoto rats were analyzed in terms of absolute hepatocyte numbers and ploidy distributions, calculated from DNA measurements made by flow cytometry and microscope counts of binucleated cells. Polyploidizing growth was observed during normal liver development, dominated by progressive polyploidization and a decrease in the number of diploid cells. Nonpolyploidizing growth was seen during liver regeneration and after treatment with 2-acetylaminofluorene (AAF). This mode of growth was characterized by an increase in all mononucleated ploidy classes in the absence of net polyploidization (no increase in binucleated cells). Additional diploid proliferation was detected after initiation with diethylnitrosamine followed by promotion with AAF. This selectively expanding diploid hepatocyte population, which persisted after AAF withdrawal, could represent the AAF-promoted progeny of diethylnitrosamine-altered cells with constitutive nonpolyploidizing growth properties.
通过流式细胞术进行的DNA测量以及双核细胞的显微镜计数计算出绝对肝细胞数量和倍性分布,据此分析正常和致癌物处理的幼年Wistar Kyoto大鼠的肝脏生长模式。在正常肝脏发育过程中观察到多倍体化生长,其主要特征是渐进性多倍体化和二倍体细胞数量减少。在肝脏再生期间以及用2-乙酰氨基芴(AAF)处理后观察到非多倍体化生长。这种生长模式的特征是在没有净多倍体化(双核细胞没有增加)的情况下,所有单核倍性类别的细胞数量增加。在用二乙基亚硝胺启动后接着用AAF促进后,检测到额外的二倍体增殖。这种选择性扩增的二倍体肝细胞群体在停用AAF后仍然存在,可能代表具有组成性非多倍体化生长特性的二乙基亚硝胺改变细胞的AAF促进后代。